Press Releases about Gilead Sciences
![](https://mms.businesswire.com/media/20240821963609/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
August 21, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240814469557/en/2216157/22/GSI_Livdelzi_58.jpg)
![](https://mms.businesswire.com/media/20240807993584/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences Announces Second Quarter 2024 Financial Results
August 08, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240724124310/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240725176931/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240724232867/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240718867405/en/2190243/22/RADIAN5138.jpg)
![](https://mms.businesswire.com/media/20240716867026/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240716578075/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240712145036_positive-news-is-driving-this-cancer-drug-makers-s.jpg)
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240621074929_gilead-sciences-stock-surges-on-hiv-treatment-tria.jpg)
![](https://mms.businesswire.com/media/20240620044585/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
![](https://mms.businesswire.com/media/20240614729632/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240606954431/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240604334684/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240603095365/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240603718191/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240531380992/en/2147242/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20240531335673/en/2147237/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20240530725767/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240530516266/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Provides Update on Phase 3 TROPiCS-04 Study
May 30, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240522704668/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://dj5dehgem20mk.cloudfront.net/img/logo-2.png)
Via PRLog
![](https://mms.businesswire.com/media/20240518003116/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240514656201/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240509189414/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.